Guggenheim Securities adjusted its financial outlook for shares of AbbVie Inc . (NYSE:ABBV), reducing the price target to $212 from the previous $221, while still recommending a Buy rating for the ...
AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...
Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback